INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 July 2016
|
Net Assets |
£223m |
|
Net Assets per share |
591p |
|
Share price |
530p |
|
Total value of unquoted investments |
£25m |
|
Total number of portfolio companies |
84 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
7.1 |
|
Regeneron |
6.5 |
|
Actelion |
4.7 |
|
Alexion |
4.7 |
|
Incyte |
4.0 |
|
Amgen |
3.7 |
|
Medivation |
3.7 |
|
Vertex |
3.6 |
|
Novo |
3.4 |
|
Biogen |
3.4 |
|
|
----------- |
|
Total |
44.8 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
75 |
|
Europe & UK |
25 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
89 |
|
Unquoted |
11 |
|
|
----------- |
|
Total |
100 |
|
NAV % Market Cap |
% NAV |
|
Large Cap >USD10BN |
68 |
|
Small Cap <USD1BN |
26 |
|
Mid Cap =USD1-10BN |
6 |
|
|
----------- |
|
Total |
100 |
|
NAV % by Therapeutic Areas |
% NAV |
|
Oncology |
37 |
|
Orphan |
22 |
|
CNS |
11 |
|
Ophthalmology |
8 |
|
Inflammation |
5 |
|
Medtech |
2 |
|
Other |
15 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 AUGUST 2016